IM-862 in Treating Patients With Recurrent Ovarian Cancer
Completed · Phase 1
Conditions studied: Ovarian Cancer
In brief
RATIONALE: IM-862 may stop the growth of ovarian cancer by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of IM-862 in treating patients who have recurrent ovarian cancer after treatment with chemotherapy and surgery.
Key facts
- Study ID
- NCT00003773
- Run by
- University of Southern California
- People needed
- 43
- Starts
- 1999-02-01
- Expected to finish
- 2001-08-01
- Last updated by the study team
- 2014-05-22
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.